Evidence map›Paper›PMID 26263963›Full record

ArticleMolecules (Basel, Switzerland)2015

Aspects of a Distinct Cytotoxicity of Selenium Salts and Organic Selenides in Living Cells with Possible Implications for Drug Design.

Ethiene Castellucci Estevam, Karolina Witek, Lisa Faulstich, Muhammad Jawad Nasim, Gniewomir Latacz, Enrique Domínguez-Álvarez, Katarzyna Kieć-Kononowicz, Marilene Demasi, Jadwiga Handzlik, Claus Jacob

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Inhibition and Inactivation of UropathogenicInternational journal of molecular sciences · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. The Reactive Sulfur Species Concept: 15 Years On.Antioxidants (Basel, Switzerland) · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Ethiene Castellucci EstevamBioorganic Chemistry, Department of Pharmacy, Saarland University, Campus B2 1, Saarbruecken D-66123, Germany. ethiene.castellucciestevam@uni-saarland.de.
Karolina WitekDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, Cracow 30-688, Poland. karolawitek.poczta@interia.pl.
Lisa FaulstichBioorganic Chemistry, Department of Pharmacy, Saarland University, Campus B2 1, Saarbruecken D-66123, Germany. lisa.faulstich@uni-saarland.de.
Muhammad Jawad NasimBioorganic Chemistry, Department of Pharmacy, Saarland University, Campus B2 1, Saarbruecken D-66123, Germany. jawad.nasim@uni-saarland.de.
Gniewomir LataczDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, Cracow 30-688, Poland. glatacz@cm-uj.krakow.pl.
Enrique Domínguez-ÁlvarezDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, Cracow 30-688, Poland. enrique.dominguez.alvarez@uj.edu.pl.
Katarzyna Kieć-KononowiczDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, Cracow 30-688, Poland. mfkonono@cyf-kr.edu.pl.
Marilene DemasiLaboratório de Bioquímica e Biofísica, Instituto Butantan, São Paulo 05503-001, Brazil. marimasi@butantan.gov.br.
Jadwiga HandzlikDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, Cracow 30-688, Poland. j.handzlik@uj.edu.pl.
Claus JacobBioorganic Chemistry, Department of Pharmacy, Saarland University, Campus B2 1, Saarbruecken D-66123, Germany. c.jacob@mx.uni-saarland.de.
Jagiellonian University · PLSaarland University · DEInstituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium is traditionally considered as an antioxidant element and selenium compounds are often discussed in the context of chemoprevention and therapy. Recent studies, however, have revealed a rather more colorful and diverse biological action of selenium-based compounds, including the modulation of the intracellular redox homeostasis and an often selective interference with regulatory cellular pathways. Our basic activity and mode of action studies with simple selenium and tellurium salts in different strains of Staphylococcus aureus (MRSA) and Saccharomyces cerevisiae indicate that such compounds are sometimes not particularly toxic on their own, yet enhance the antibacterial potential of known antibiotics, possibly via the bioreductive formation of insoluble elemental deposits. Whilst the selenium and tellurium compounds tested do not necessarily act via the generation of Reactive Oxygen Species (ROS), they seem to interfere with various cellular pathways, including a possible inhibition of the proteasome and hindrance of DNA repair. Here, organic selenides are considerably more active compared to simple salts. The interference of selenium (and tellurium) compounds with multiple targets could provide new avenues for the development of effective antibiotic and anticancer agents which may go well beyond the traditional notion of selenium as a simple antioxidant.

Indexed as

Drug DesignAnti-Infective AgentsCell DeathCell SurvivalChalcogensMicrobial Sensitivity TestsOrganoselenium CompoundsOxidation-ReductionProteasome InhibitorsReactive Oxygen SpeciesSaccharomyces cerevisiaeSaltsSeleniumStaphylococcus aureusTelluriumAnti-Infective AgentsChalcogensOrganoselenium CompoundsProteasome InhibitorsReactive Oxygen SpeciesSaltsSeleniumTelluriumcellular thiolstatMRSAproteasomeredox modulationresistant bacteriaROSseleniumtelluriumyeast

Identifiers

PMID26263963
PMCPMC6331825
OpenAlexW1940579097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.